Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 10:45 (1701 d 10:26 ago) – Posting: # 20125
Views: 3,515

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,811 posts in 4,783 threads, 1,643 registered users;
34 visitors (0 registered, 34 guests [including 6 identified bots]).
Forum time: 20:12 CET (Europe/Vienna)

Nothing shocks me. I’m a scientist.    Harrison Ford (as Indiana Jones)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5